FREE Account Opening + No Clearing Fees
Loading...
Solara Active Pharma Sciences Rights Issue 2024 Detail
Issue Open May 28, 2024
Issue Close June 11, 2024
Issue Size (Shares) 1.20 Crores
Issue Size (Amount) ₹449.95 Crores
Issue Price ₹375 per Share
Listing At BSE, NSE

Solara Active Pharma Sciences Rights Issue 2024 Date & Price FAQs

Solara Active Pharma Sciences Rights Issue 2024 Timetable

Last Date for credit of Rights EntitlementsMay 27, 2024
Last Date for renunciation of Rights EntitlementsJune 5, 2024
Issue Opening DateMay 28, 2024
Issue Closing DateJune 11, 2024
Allotment DateJune 19, 2024
Shares Credit DateJune 19, 2024
Listing DateJune 20, 2024

Solara Active Pharma Sciences Rights Issue 2024 price is set at ₹375 per Share. The Solara Active Pharma Sciences Rights Issue 2024 opens on May 28, 2024, and closes on June 11, 2024, for the subscription.

The allotment of Solara Active Pharma Sciences Rights Issue 2024 is expected to happen on or about June 19, 2024 as per the issue schedule.

Solara Active Pharma Sciences Rights Issue 2024 expected to list on or around June 20, 2024.

The credit of Solara Active Pharma Sciences Rights Issue 2024 in Demat account is expected on or about June 19, 2024 as per the issue schedule.

The company intends to utilize the Net Proceeds from the Issue towards the following objects:

  1. Repayment and/or pre-payment, in full or part, of certain outstanding borrowings availed by the company; and
  2. General corporate purposes.

It is difficult to say at what price Solara Active Pharma Sciences Rights Issue 2024 shares will list. The price depends on the demand and supply of company's shares on the day of listing.

Sorry, we do not provide rights issue's recommendations. But we share a lot of information about Solara Active Pharma Sciences Rights Issue 2024 which could help you with questions like Solara Active Pharma Sciences Rights Issue 2024 buy or not? Consider reading Solara Active Pharma Sciences Rights Issue 2024 reviews and analysis from experts posted on rights issue detail page.

Comments

Add a public comment...